Source: iQoncept / Shutterstock
Avalo Therapeutics (NASDAQ:AVTX) just reported results for the first quarter of 2024.
- Avalo Therapeutics reported earnings per share of -$6.11. This was below the analyst estimate for EPS of -$1.18.
- The company did not report any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/avtx-stock-earnings-avalo-therapeutics-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC